PDS Share Price

PDS Share Price

NASDAQ: PDSB | Micro Cap | Healthcare
$0.81
-$0.09 (-9.79%) Last updated on 19 Nov, 2026 | 03:22 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

PDS Stock Performance

Open
$0.90
Prev. Close
$0.89
Circuit Range
N/A
Day Range
$0.76 - $0.91
Year Range
$0.20 - $1.78
Volume
55,749
Average Traded
$0.82

PDS Share Price Today

As of 19 November 2026, PDS Biotechnology Corporation's share price is $0.81. The stock opened at $0.90, compared to its previous close of $0.89. During today's trading session, PDS Biotechnology Corporation's share price traded between $0.76 and $0.91, with an average price of $0.83. Over the past 52 weeks, the stock has recorded a high of $1.78 and a low of $0.20. In terms of performance, PDS Biotechnology Corporation's share price has declined by 26.04% over the last six months and is up 4.29% on a year-on-year basis.

PDS Share Price Chart

Line chart of the PDS price trend over the selected period. The price fell overall, ranging from 0.76 to 0.91, ending at 0.80.
$0.76$0.91
L
Show Current Price
H

PDS Stock Fundamentals & Key Indicators

Market Cap
$37.40M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.27
Revenue (TTM)
$0.00
Return On Equity (TTM)
940.63%
Profit Margin
N/A
Debt to Equity
-1.22
Quarterly Earnings Growth YoY
-8.21%

PDS Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.01-$7.56-$7.35-$9.75
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A16.09%2.78%-32.65%

PDS Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$40.85-$42.94-$37.61-$34.50
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.12%12.41%8.27%

PDS Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.240.30.340.53
Current Assets28.2545.0559.0676.48
Total Assets30.4945.3659.3977.01
Non Current Liabilities11.769.2719.6323.18
Current Liabilities9.4817.0913.639.82
Total Liabilities21.2426.3533.2633.01
Shareholders' Equity9.2519.026.1344.0

PDS Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-27.75-35.03-33.64-25.71
Investing0.0-0.030.00.0
Financing12.7720.1916.3834.29

About PDS

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

PDS Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.49
$0.80
-44.60%
Oct 2026
$0.74
$1.44
+96.84%
Sep 2026
$0.20
$0.73
+239.07%
Aug 2026
$0.70
$0.21
-68.57%
Jul 2026
$0.87
$0.68
-21.65%
Jun 2026
$1.07
$0.87
-19.91%
May 2026
$0.99
$1.09
+7.50%
Apr 2026
$0.60
$1.01
+70.71%
Mar 2026
$0.66
$0.59
-11.34%
Feb 2026
$0.83
$0.67
-19.86%
Jan 2026
$0.79
$0.84
+8.57%
Dec 2025
$0.75
$0.77
-0.39%

PDS Share Price FAQs